Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

    Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond ME, Harrison SD.

    Diabetes. 2003 Mar;52(3):588-95.PMID: 12606497 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Chemical conjugation of a novel antibody-interleukin 2 immunoconjugate against c-erbB-2 product.

    Li J, Lee SE, Belciug M, Ring DB, Kwok CS.

    Chin Med J (Engl). 2000 Feb;113(2):151-3.PMID: 11775541 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.

    Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA.

    Hum Gene Ther. 1999 Jun 10;10(9):1453-67.PMID: 10395371 [PubMed - indexed for MEDLINE]Related articles

    4.

    Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment.

    Clark JI, Alpaugh RK, von Mehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM.

    Cancer Immunol Immunother. 1997 Jul;44(5):265-72.PMID: 9247561 [PubMed - indexed for MEDLINE]Related articles

    5.

    In vitro tumor growth inhibition by bispecific antibodies to human transferrin receptor and tumor-associated antigens is augmented by the iron chelator deferoxamine.

    Hsieh-Ma ST, Shi T, Reeder J, Ring DB.

    Clin Immunol Immunopathol. 1996 Aug;80(2):185-93.PMID: 8764564 [PubMed - indexed for MEDLINE]Related articles

    6.

    Human neutrophil interactions of a bispecific monoclonal antibody targeting tumor and human Fc gamma RIII.

    Weiner LM, Alpaugh RK, Amoroso AR, Adams GP, Ring DB, Barth MW.

    Cancer Immunol Immunother. 1996 Mar;42(3):141-50.PMID: 8640842 [PubMed - indexed for MEDLINE]Related articles

    7.

    Murine bispecific antibody 1A10 directed to human transferrin receptor and a 42-kDa tumor-associated glycoprotein.

    Shi T, Hsieh-Ma ST, Reeder J, Ring DB.

    Clin Immunol Immunopathol. 1996 Feb;78(2):188-95.PMID: 8625561 [PubMed - indexed for MEDLINE]Related articles

    8.

    Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

    Amoroso AR, Clark JI, Litwin S, Hsieh-Ma S, Shi T, Alpaugh RK, Adams GP, Wolf EJ, Ring DB, Weiner LM.

    Cancer Res. 1996 Jan 1;56(1):113-20.PMID: 8548750 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

    Weiner LM, Clark JI, Davey M, Li WS, Garcia de Palazzo I, Ring DB, Alpaugh RK.

    Cancer Res. 1995 Oct 15;55(20):4586-93.PMID: 7553634 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.

    Weiner LM, Clark JI, Ring DB, Alpaugh RK.

    J Hematother. 1995 Oct;4(5):453-6.PMID: 8581384 [PubMed - indexed for MEDLINE]Related articles

    11.

    High-affinity monoclonal antibodies against P-glycoprotein.

    Shi T, Wrin J, Reeder J, Liu D, Ring DB.

    Clin Immunol Immunopathol. 1995 Jul;76(1 Pt 1):44-51.PMID: 7541735 [PubMed - indexed for MEDLINE]Related articles

    12.

    Antigen forks: bispecific reagents that inhibit cell growth by binding selected pairs of tumor antigens.

    Ring DB, Hsieh-Ma ST, Shi T, Reeder J.

    Cancer Immunol Immunother. 1994 Jul;39(1):41-8.PMID: 8044825 [PubMed - indexed for MEDLINE]Related articles

    13.

    Binding and cytotoxicity characteristics of the bispecific murine monoclonal antibody 2B1.

    Weiner LM, Holmes M, Richeson A, Godwin A, Adams GP, Hsieh-Ma ST, Ring DB, Alpaugh RK.

    J Immunol. 1993 Sep 1;151(5):2877-86.PMID: 8103070 [PubMed - indexed for MEDLINE]Related articles

    14.
    15.

    Selection of hybrid hybridomas by flow cytometry using a new combination of fluorescent vital stains.

    Shi T, Eaton AM, Ring DB.

    J Immunol Methods. 1991 Aug 9;141(2):165-75.PMID: 1715368 [PubMed - indexed for MEDLINE]Related articles

    16.

    Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal antibodies with recombinant c-erbB-2.

    Ring DB, Clark R, Saxena A.

    Mol Immunol. 1991 Aug;28(8):915-7. Erratum in: Mol Immunol 1992 Feb;29(2):291-2. PMID: 1715033 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.

    Shannon KM, Ring DB, Houston LL, Schaffner V, Naylor J, Torkildson JC, Reid SA, Larrick J.

    Int J Cell Cloning. 1990 Sep;8(5):368-76.PMID: 2230286 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology.

    Leslie DS, Johnston WW, Daly L, Ring DB, Shpall EJ, Peters WP, Bast RC Jr.

    Am J Clin Pathol. 1990 Jul;94(1):8-13.PMID: 2193508 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cells.

    Yu YH, Crews JR, Cooper K, Ramakrishnan S, Houston LL, Leslie DS, George SL, Lidor Y, Boyer CM, Ring DB, et al.

    Cancer Res. 1990 Jun 1;50(11):3231-8.PMID: 2334918 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Distribution and physical properties of BCA200, a Mr 200,000 glycoprotein selectively associated with human breast cancer.

    Ring DB, Kassel JA, Hsieh-Ma ST, Bjorn MJ, Tringale F, Eaton AM, Reid SA, Frankel AE, Nadji M.

    Cancer Res. 1989 Jun 1;49(11):3070-80.PMID: 2470501 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Targeted cytotoxic cells as a novel form of cancer immunotherapy.

    Segal DM, Garrido MA, Perez P, Titus JA, Winkler DA, Ring DB, Kaubisch A, Wunderlich JR.

    Mol Immunol. 1988 Nov;25(11):1099-103. No abstract available. PMID: 3265476 [PubMed - indexed for MEDLINE]Related articles

    22.

    Heritable variation in expression of multiple tumor associated epitopes on a high molecular weight mucin-like antigen.

    Linsley PS, Ochs V, Horn D, Ring DB, Frankel AE.

    Cancer Res. 1986 Dec;46(12 Pt 1):6380-6.PMID: 2430697 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.

    Linsley PS, Ochs V, Laska S, Horn D, Ring DB, Frankel AE, Brown JP.

    Cancer Res. 1986 Oct;46(10):5444-50.PMID: 2428478 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Selective inhibition of the growth of human erythroid bursts by monoclonal antibodies against transferrin or the transferrin receptor.

    Shannon KM, Larrick JW, Fulcher SA, Burck KB, Pacely J, Davis JC, Ring DB.

    Blood. 1986 Jun;67(6):1631-8.PMID: 3011150 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.

    Frankel AE, Ring DB, Tringale F, Hsieh-Ma ST.

    J Biol Response Mod. 1985 Jun;4(3):273-86.PMID: 4020386 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...